Prolor Biotech (PBTH), will be acquired by OPKO Health (OPK) in an all-stock deal worth $480M....

|By:, SA News Editor

Prolor Biotech (PBTH), will be acquired by OPKO Health (OPK) in an all-stock deal worth $480M. PBTH shareholders will get 0.9551 shares of OPK for every share of PBTH they own, equating to $7 per share as of Tuesday's closing prices. PBTH +10.65% premarket. (Previously: strategic alternative evaluation boosts Prolor)